The U.S. National Institute of Mental Health's Project Accept — a trial conducted by the HIV Prevention Trials Network to test a combination of social, behavioral and structural HIV-prevention interventions — demonstrated that a series of community efforts was able to boost the number of people tested for HIV and resulted in a 14 percent reduction in new HIV infections, compared with control communities.
"These study results clearly demonstrate that high rates of testing can be achieved by going into communities and that this strategy can result in increased HIV detection, which makes referral to care possible," said Project Accept's overall principal investigator, Thomas J. Coates, who directs UCLA's Center for World Health and is an associate director of the UCLA AIDS Institute. "This has major public health benefit implications by not only linking infected individuals to care but also by encouraging testing in entire communities and therefore also reducing further HIV transmission."
The trial was conducted in 34 communities in South Africa, Tanzania and Zimbabwe and in 14 communities in Thailand. It consisted of mobile HIV testing, post-test support services and real-time feedback.
The aim of the intervention was four-fold: (1) to increase access to voluntary counseling and testing, as well as post-test services; (2) to change community attitudes about HIV awareness and particularly about the benefit of knowing one's HIV status; (3) to remove barriers to knowing one's HIV status; and (4) to increase the safety of testing and minimize the potential negative consequences of testing by providing various forms of support.
Communities were matched into pairs based on sociodemographic, cultural and infrastructure characteristics, with one community randomly assigned to the intervention and one serving as a control for comparison. (The randomization was performed centrally, and the assignment was not blinded, due to the nature of the intervention.)
Among the findings:
Rates of testing were 45 percent higher in intervention communities than control communities, especially among men and young people.
Individuals in intervention communities, particularly those infected with HIV, reported a lower number of sexual partners and fewer multiple partners. This was particularly true among HIV-positive men, who reported 18 percent fewer sexual partners overall and 29 percent fewer concurrent sexual partners than those in control communities.
Diagnoses of HIV infection were higher in intervention communities.
Social acceptance of the importance of testing was higher in intervention communities.
Modest reductions in HIV incidence occurred in the intervention communities, compared with the control communities, particularly among women in the 25-to-32 age range.
Study participants who learned they were infected with HIV were directed to the study's post-test services, which included counseling and referrals to health and social services assistance. Those who tested negative were also directed to post-test services for further counseling, referrals and support to help ensure they remained uninfected. Local health authorities were thoroughly briefed on the study findings and encouraged to continue the implementation efforts.
Individuals need to be made aware of their HIV status through testing in order to receive the necessary care and treatment and learn how to prevent infection, said Dr. Wafaa El-Sadr, principal investigator of the HIV Prevention Trials Network, under whose auspices the trial was conducted.
"These study findings provide clear and compelling evidence that the provision of mobile services, combined with appropriate support activities, is a strategy that can increase testing rates and also reduce HIV incidence," she said.
The U.S. National Institute of Mental Health (grants 5U01MH066687, 5U01MH066688, 5U01MH066701 and 5U01MH066702); the U.S. National Institute of Allergy and Infectious Diseases; and the Office of AIDS Research, all components of the U.S. National Institutes of Health, funded this research.
The HIV Prevention Trials Network (HPTN) is a worldwide collaborative clinical trials network that develops and tests the safety and efficacy of interventions designed to prevent the acquisition and transmission of HIV. The HPTN research agenda is focused primarily reducing HIV transmission and acquisition through the use of antiretroviral therapy for HIV-infected persons and antiretrovirals as pre-exposure prophylaxis for HIV-negative persons; reducing the impact of behavioral and biologic co-factors that increase the risk of infection; treating substance abuse (particularly injection-drug use); reducing behavioral risk through interventions; and structural interventions. The highest priority of the HPTN is to develop and implement combination prevention strategies that demonstrate a significant and measurable reduction in HIV incidence in a variety of populations and epidemic settings.
The UCLA Center for World Health is a joint initiative of the David Geffen School of Medicine at UCLA and UCLA Health. The goal of CWH is to make UCLA a recognized global leader in health education, research and service, with a reputation for excellence in improving the health of the world's people. The center is led by Thomas J. Coates, a professor of medicine in the division of infectious diseases, and J. Thomas Rosenthal, a professor of urology and chief medical officer for UCLA Health.
The UCLA AIDS Institute, established in 1992, is a multidisciplinary think tank drawing on the skills of top-flight researchers in the worldwide fight against HIV and AIDS, the first cases of which were reported in 1981 by UCLA physicians. Institute members include researchers in virology and immunology, genetics, cancer, neurology, ophthalmology, epidemiology, social sciences, public health, nursing and disease prevention. Their findings have led to advances in treating HIV, as well as other diseases, such as hepatitis B and C, influenza and cancer.
For more news, visit the UCLA Newsroom and follow us on Twitter.
Enrique Rivero | EurekAlert!
Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania
The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.
The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
17.01.2017 | Earth Sciences
17.01.2017 | Materials Sciences
17.01.2017 | Architecture and Construction